9/26/2022 6:50:27 AM
Pfizer, BioNTech Submit Application To FDA For EUA Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Children
9/22/2022 8:04:59 AM
Pfizer Declares Q4 Dividend Of $0.40/shr; Payable December 5/record November 4
9/22/2022 8:04:27 AM
Pfizer Inc. (PFE) Declares $ 0.40 Dividend for Q4 22, Record Date 11/4/2022
9/22/2022 6:48:42 AM
Pfizer Agrees To Supply Global Fund Up To 6 Mln PAXLOVID Treatment Courses For Low-and-Middle-Income Countries
9/19/2022 6:48:34 AM
Pfizer Reports Positive Top-Line Results From Phase 3 Study In 20-Valent Pneumococcal Conjugate Vaccine In Infants In EU
9/16/2022 8:13:14 AM
Pfizer, BioNTech Get Positive CHMP Opinion For Conversion Of COMIRNATY To Full Marketing Authorization
9/15/2022 6:51:40 AM
Pfizer Announces Positive Top-Line Results From Phase 3 Trial Of MenABCWY In Adolescents
9/14/2022 6:51:11 AM
Pfizer Initiates Phase 3 Study Of MRNA-Based Influenza Vaccine
9/13/2022 8:49:25 AM
Strata Oncology Announces Expansion Of Collaboration With Pfizer For Strata PATH Trial Into Early-Stage Cancer
9/12/2022 11:34:24 AM
Pfizer And BioNTech Receive Positive CHMP Opinion For Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster In EU